Results 171 to 180 of about 11,312 (241)

Next-Generation HER2-Targeted Antibody-Drug Conjugates in Breast Cancer. [PDF]

Cancers (Basel)
Zimmerman BS, Esteva FJ.
europepmc   +1 more source

HER2-targeted therapies for HER2-positive early-stage breast cancer: present and future. [PDF]

Front Pharmacol
Xu L, Xie Y, Gou Q, Cai R, Bao R, Huang Y, Tang R.   +6 more
europepmc   +1 more source

Leopold Kretzenbacher, Schutz- und Bittgebarden der Gottesmutter, Bayerische Akademie der Wissenschaften, Philosophisch historische Klasse, Sitzungsberichte, Jahrgang 1981, Heft 3, Munchen 1981, 112 str. + 14 tabli. [PDF]

, 1982
Anđelko Badurina
core   +1 more source

Barok Dönem Osmanlı Müziğinde Metinlerarası İzler

, 2022
M. Ayça ÖNAL
openalex   +1 more source

Nature's carriers: leveraging extracellular vesicles for targeted drug delivery. [PDF]

Drug Deliv
Chen Q, Zheng Y, Jiang X, Wang Y, Chen Z, Wu D.   +5 more
europepmc   +1 more source

Trastuzumab emtansine: mechanisms of action and drug resistance. [PDF]

Breast Cancer Res, 2014
Barok M, Joensuu H, Isola J.
europepmc   +1 more source

Sense meets sensibility [PDF]

, 2015
Forment, Bruno
core   +1 more source

Postmodern Cephe Estetiğinde Barok Bir Yöntem Olarak Teatral Anlatım İlkeleri

, 2015
Tuğba Erdil Polat, Ayla Fatma Antel
openalex   +2 more sources

Efficacy and safety of antibody-drug conjugates in the treatment of urothelial cell carcinoma: a systematic review and meta-analysis of prospective clinical trials. [PDF]

Front Pharmacol
Ren JW, Chen ZY, Bai YJ, Han P.
europepmc   +1 more source